2701 - 2750 of 8471 Results
Title
Year
-
OPENTitle: Machine Learning Identifies Six Genetic Variants and Alterations in the Heart Atrial Appendage as Key Contributors to PD Risk PredictivityJournal Name: Frontiers in GeneticsPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fgene.2021.785436Best OA location URL: https://www.frontiersin.org/articles/10.3389/fgene.2021.785436/pdfCitation Count: 6
-
OPENTitle: Predicting survival in patients with glioblastoma using MRI radiomic features extracted from radiation planning volumesJournal Name: Journal of Neuro-OncologyPublisher: Springer Science and Business Media LLCVol: 156Issue #: 3Start Page: 579End Page: 588Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11060-021-03939-9Best OA location URL: https://www.researchsquare.com/article/rs-1078827/latest.pdfCitation Count: 5
-
OPENTitle: The National Institute on Aging Late‐Onset Alzheimer's Disease Family Based Study: A resource for genetic discoveryJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 10Start Page: 1889End Page: 1897Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12514Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12514Citation Count: 17
-
OPENTitle: A novel process driving Alzheimer's disease validated in a mouse model: Therapeutic potentialJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/trc2.12274Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/trc2.12274Citation Count: 23
-
OPENTitle: A Spatiotemporal Map of the Aging Mouse Brain Reveals White Matter Tracts as Vulnerable FociJournal Name: SSRN Electronic JournalPublisher: Elsevier BVVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2139/ssrn.4260648Best OA location URL: https://doi.org/10.1101/2022.09.18.508419Citation Count: 2
-
OPENTitle: Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsyJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 34Issue #:Start Page: 103022End Page: 103022Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2022.103022Best OA location URL: https://doi.org/10.1016/j.nicl.2022.103022Citation Count: 24
-
OPENTitle: Alpha synuclein, the culprit in Parkinson disease, is required for normal immune functionJournal Name: Cell ReportsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 110090End Page: 110090Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2021.110090Best OA location URL: http://www.cell.com/article/S2211124721015813/pdfCitation Count: 78
- An atypical ubiquitin ligase at the heart of neural development and programmed axon degeneration2022RESTRICTEDTitle: An atypical ubiquitin ligase at the heart of neural development and programmed axon degenerationJournal Name: Neural Regeneration ResearchPublisher: MedknowVol: 17Issue #: 11Start Page: 2347End Page: 2347Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.4103/1673-5374.338992Best OA location URL: https://doi.org/10.4103/1673-5374.338992Citation Count: 8
- Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases2022RESTRICTEDTitle: Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseasesJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 298Issue #: 1Start Page: 101478End Page: 101478Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jbc.2021.101478Best OA location URL: http://www.jbc.org/article/S0021925821012874/pdfCitation Count: 19
-
OPENTitle: Association between cigarette smoking and Parkinson’s disease: a neuroimaging studyJournal Name: Therapeutic Advances in Neurological DisordersPublisher: SAGE PublicationsVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/17562864221092566Best OA location URL: https://doi.org/10.1177/17562864221092566Citation Count: 26
-
OPENTitle: Association of vitamin K with cognitive decline and neuropathology in community‐dwelling older personsJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12255Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/trc2.12255Citation Count: 39
-
OPENTitle: At a Glance: An Update on Neuroimaging and Retinal Imaging in Alzheimer’s Disease and Related ResearchJournal Name: The Journal of Prevention of Alzheimer's DiseasePublisher: Elsevier BVVol: 9Issue #: 1Start Page: 1End Page: 10Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.14283/jpad.2022.7Best OA location URL: https://link.springer.com/content/pdf/10.14283/jpad.2022.7.pdfCitation Count: 1
- c‐Abl Inhibitors as Disease‐Modifying Therapies for Parkinson's Disease: Gaps and Opportunities2022RESTRICTEDTitle: c‐Abl Inhibitors as Disease‐Modifying Therapies for Parkinson's Disease: Gaps and OpportunitiesJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 3End Page: 5Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28907Citation Count: 3
-
OPENTitle: Cerebral topography of vesicular cholinergic transporter changes in neurologically intact adults: A [18F]FEOBV PET studyJournal Name: Aging BrainPublisher: Elsevier BVVol: 2Issue #:Start Page: 100039End Page: 100039Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbas.2022.100039Best OA location URL: https://doi.org/10.1016/j.nbas.2022.100039Citation Count: 29
-
RESTRICTEDTitle: Characterization of Axon Guidance Phenotypes in Wnt/PCP Mutant MiceJournal Name: Methods in Molecular BiologyPublisher: Springer USVol:Issue #:Start Page: 277End Page: 286Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/978-1-0716-2035-9_17Citation Count: 3
-
RESTRICTEDTitle: Clinical neurophysiology of Parkinson’s disease and parkinsonismJournal Name: Clinical Neurophysiology PracticePublisher: Elsevier BVVol: 7Issue #:Start Page: 201End Page: 227Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cnp.2022.06.002Best OA location URL: https://doi.org/10.1016/j.cnp.2022.06.002Citation Count: 33
-
OPENTitle: Concurrent validity of Zeno instrumented walkway and video-based gait features in adults with Parkinson’s diseaseJournal Name: IEEE Journal of Translational Engineering in Health and MedicinePublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 10Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1109/jtehm.2022.3180231Best OA location URL: https://ieeexplore.ieee.org/ielx7/6221039/6563131/09787410.pdfCitation Count: 24
-
RESTRICTEDTitle: Considerations for clinical trial design and conduct in the evaluation of novel advanced therapeutics in neurodegenerative diseaseJournal Name: International Review of NeurobiologyPublisher: ElsevierVol:Issue #:Start Page: 235End Page: 279Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/bs.irn.2022.09.006Citation Count: 0
-
OPENTitle: Deep learning for Parkinson’s disease symptom detection and severity evaluation using accelerometer signalJournal Name: ESANN 2022 proceedingsPublisher: Ciaco - i6doc.comVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.14428/esann/2022.es2022-107Best OA location URL: https://doi.org/10.14428/esann/2022.es2022-107Citation Count: 0
-
OPENTitle: Define and visualize pathological architectures of human tissues from spatially resolved transcriptomics using deep learningJournal Name: Computational and Structural Biotechnology JournalPublisher: Elsevier BVVol: 20Issue #:Start Page: 4600End Page: 4617Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.csbj.2022.08.029Best OA location URL: https://doi.org/10.1016/j.csbj.2022.08.029Citation Count: 37
-
RESTRICTEDTitle: Depression and Parkinson's disease: a Chicken-Egg storyJournal Name: AIMS NeurosciencePublisher: American Institute of Mathematical Sciences (AIMS)Vol: 9Issue #: 4Start Page: 479End Page: 490Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3934/neuroscience.2022027Best OA location URL: https://doi.org/10.3934/neuroscience.2022027Citation Count: 2
-
OPENTitle: Detection of emerging neurodegeneration using Bayesian linear mixed-effect modelingJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 36Issue #:Start Page: 103144End Page: 103144Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nicl.2022.103144Best OA location URL: https://doi.org/10.1016/j.nicl.2022.103144Citation Count: 6
-
OPENTitle: Distinct atrophy of septal nuclei in Parkinson’s diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 7Issue #:Start Page: 100171End Page: 100171Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100171Best OA location URL: https://doi.org/10.1016/j.prdoa.2022.100171Citation Count: 1
-
OPENTitle: DNA Sequence Analysis for Brain Disorder Using Deep Learning and Secure StorageJournal Name: Computers, Materials & ContinuaPublisher: Tech Science PressVol: 71Issue #: 3Start Page: 5949End Page: 5962Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.32604/cmc.2022.022028Best OA location URL: https://www.techscience.com/cmc/v71n3/46465/pdfCitation Count: 5
- Drug News2022RESTRICTEDTitle: Drug NewsJournal Name: NursingPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 52Issue #: 1Start Page: 8End Page: 9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nurse.0000803500.30920.0cCitation Count: 0
-
OPENTitle: Early Autonomic Symptoms Predict Functional Decline in Parkinson’s Disease Independent of Dopaminergic TherapyJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 22Issue #: 1Start Page: 15End Page: 23Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000525664Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671814Citation Count: 3
-
RESTRICTEDTitle: Environmental neurotoxicants and inflammasome activation in Parkinson’s disease – A focus on the gut-brain axisJournal Name: The International Journal of Biochemistry & Cell BiologyPublisher: Elsevier BVVol: 142Issue #:Start Page: 106113End Page: 106113Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.biocel.2021.106113Citation Count: 8
-
OPENTitle: Evaluation of morning bradykinesia in Parkinson’s disease in a United States cohort using continuous objective monitoringJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 6Issue #:Start Page: 100145End Page: 100145Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100145Best OA location URL: https://doi.org/10.1016/j.prdoa.2022.100145Citation Count: 8
-
RESTRICTEDTitle: Evaluation of the Dementia Apraxia Test in Parkinson’s Disease PatientsJournal Name: Dementia and Geriatric Cognitive DisordersPublisher: S. Karger AGVol: 51Issue #: 3Start Page: 271End Page: 278Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1159/000525618Citation Count: 2
-
RESTRICTEDTitle: Exploration of Protein Aggregations in Parkinson’s Disease Through Computational Approaches and Big Data AnalyticsJournal Name: Methods in Molecular BiologyPublisher: Springer USVol:Issue #:Start Page: 449End Page: 467Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/978-1-0716-1546-1_19Citation Count: 2
-
RESTRICTEDTitle: Extracellular vesicles in pharmacology: Novel approaches in diagnostics and therapyJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 175Issue #:Start Page: 105980End Page: 105980Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.phrs.2021.105980Best OA location URL: http://manuscript.elsevier.com/S1043661821005648/pdf/S1043661821005648.pdfCitation Count: 12
-
OPENTitle: GaitForeMer: Self-supervised Pre-training of Transformers via Human Motion Forecasting for Few-Shot Gait Impairment Severity EstimationJournal Name: Lecture Notes in Computer SciencePublisher: Springer Nature SwitzerlandVol:Issue #:Start Page: 130End Page: 139Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/978-3-031-16452-1_13Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9635991Citation Count: 14
-
OPENTitle: Gastric acid suppressants and cognitive decline in people with or without cognitive impairmentJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12243Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/trc2.12243Citation Count: 11
-
RESTRICTEDTitle: Hippocampal Functional Connectivity in Parkinson’s DiseaseJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 22Issue #: 1Start Page: 29End Page: 33Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1159/000526377Citation Count: 6
-
RESTRICTEDTitle: Inclusionary Trials: A Review of Lessons Not LearnedJournal Name: Epidemiologic ReviewsPublisher: Oxford University Press (OUP)Vol: 44Issue #: 1Start Page: 78End Page: 86Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/epirev/mxac007Best OA location URL: https://academic.oup.com/epirev/advance-article-pdf/doi/10.1093/epirev/mxac007/45890462/mxac007.pdfCitation Count: 6
-
RESTRICTEDTitle: Integrating Multimorbidity into a Whole-Body Understanding of Disease Using Spatial GenomicsJournal Name: Results and Problems in Cell DifferentiationPublisher: Springer International PublishingVol:Issue #:Start Page: 157End Page: 187Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/978-3-031-06573-6_5Citation Count: 0
-
OPENTitle: Machine Learning-Based Prediction of Impulse Control Disorders in Parkinson’s Disease From Clinical and Genetic DataJournal Name: IEEE Open Journal of Engineering in Medicine and BiologyPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 3Issue #:Start Page: 96End Page: 107Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1109/ojemb.2022.3178295Best OA location URL: https://ieeexplore.ieee.org/ielx7/8782705/8937520/09783181.pdfCitation Count: 9
-
OPENTitle: Mapping of a N-terminal α-helix domain required for human PINK1 stabilization, Serine228 autophosphorylation and activation in cellsJournal Name: Open BiologyPublisher: The Royal SocietyVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1098/rsob.210264Best OA location URL: https://doi.org/10.1098/rsob.210264Citation Count: 33
- Metabolic brain pattern in dementia with Lewy bodies: Relationship to Alzheimer’s disease topography2022OPENTitle: Metabolic brain pattern in dementia with Lewy bodies: Relationship to Alzheimer’s disease topographyJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 35Issue #:Start Page: 103080End Page: 103080Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2022.103080Best OA location URL: https://doi.org/10.1016/j.nicl.2022.103080Citation Count: 15
-
OPENTitle: NigraNet: An automatic framework to assess nigral neuromelanin content in early Parkinson’s disease using convolutional neural networkJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 36Issue #:Start Page: 103250End Page: 103250Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2022.103250Best OA location URL: https://doi.org/10.1016/j.nicl.2022.103250Citation Count: 9
-
OPENTitle: Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core studyJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12329Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398229Citation Count: 13
- Poster Session2022OPENTitle: Poster SessionJournal Name: Rinsho ShinkeigakuPublisher: Societas Neurologica JaponicaVol: 62Issue #: SupplementStart Page: S247End Page: S393Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.5692/clinicalneurol.62_supplement_s247Best OA location URL: https://www.jstage.jst.go.jp/article/clinicalneurol/62/Supplement/62_62_supplement_S247/_pdfCitation Count: 2
-
OPENTitle: POSTERS - 15th Conference Clinical Trials Alzheimer’s Disease, November 29- December 2, 2022, San Francisco, CA, USAJournal Name: The Journal of Prevention of Alzheimer's DiseasePublisher: Elsevier BVVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.14283/jpad.2022.97Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734609Citation Count: 5
-
RESTRICTEDTitle: Should “on-demand” treatments for Parkinson’s disease OFF episodes be used earlier?Journal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 7Issue #:Start Page: 100161End Page: 100161Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100161Best OA location URL: https://doi.org/10.1016/j.prdoa.2022.100161Citation Count: 7
-
OPENTitle: Sorting (Nexin-13) out Novel Insights into Endolysosomal Cholesterol ExportJournal Name: ContactPublisher: SAGE PublicationsVol: 5Issue #:Start Page: 251525642211145End Page: 251525642211145Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/25152564221114513Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/25152564221114513Citation Count: 2
-
OPENTitle: Subcellular and regional localization of mRNA translation in midbrain dopamine neuronsJournal Name: Cell ReportsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 110208End Page: 110208Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2021.110208Best OA location URL: http://www.cell.com/article/S2211124721017125/pdfCitation Count: 41
-
RESTRICTEDTitle: The many genomes of Parkinson's diseaseJournal Name: International Review of NeurobiologyPublisher: ElsevierVol:Issue #:Start Page: 59End Page: 80Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/bs.irn.2022.07.007Citation Count: 3
-
RESTRICTEDTitle: The neuropsychiatry of Parkinson's disease: advances and challengesJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 1Start Page: 89End Page: 102Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00330-6Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800169Citation Count: 151
-
RESTRICTEDTitle: Therapeutics in the Pipeline Targetingα-Synuclein for Parkinson's DiseaseJournal Name: Pharmacological ReviewsPublisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)Vol: 74Issue #: 1Start Page: 207End Page: 237Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1124/pharmrev.120.000133Best OA location URL: https://pharmrev.aspetjournals.org/content/pharmrev/74/1/207.full.pdfCitation Count: 39
-
RESTRICTEDTitle: Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disordersJournal Name: Pharmacology & TherapeuticsPublisher: Elsevier BVVol: 229Issue #:Start Page: 107937End Page: 107937Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pharmthera.2021.107937Citation Count: 34